Navigation Links
Quintessence cancer treatment chosen for clinical studies

Madison, Wis. - Quintessence Biosciences, a biopharmaceutical company developing cancer therapies, has announced that QB139, one of its EVade cancer treatments, has been selected for preclinical testing and human clinical trials.

Quintessence said that pending a favorable preclinical safety assessment, it would submit to the

Source:wistechnology.com By WTN News 11/09/06


Page: 1

Related biology technology :

1. Quintessence Biosciences advances cancer drug
2. Quintessence Biosciences names new president
3. Quintessence division to develop drug tests with NIH grant
4. Quintessence Biosciences forms cancer therapeutic advisory board
5. Quintessence Secures Financing
6. NeoClone gets $750K for ovarian cancer detection
7. Medical College receives $1.4M cancer grant
8. GE Healthcare partners with UNC on breast cancer imaging research
9. Lance Armstrong and the future of cancer care
10. Medical College part of $5M cancer study
11. UW finds new path to anti-cancer agents
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/19/2019)... ... 2019 , ... Bogey was nine years old when he injured both of his cruciate ligaments. ... ailments caused Bogey to experience problems with his mobility. According to his owners, he ... spot on the couch. , His owners, devastated at the sight of Bogey in so ...
(Date:3/18/2019)... ... March 18, 2019 , ... For more than 15 years, USDM ... allow life science companies to easily comply with FDA 21 CFR Part 11 and ... a managed service delivering end-to-end GxP compliance from vendor audit through ongoing validation maintenance, ...
(Date:3/14/2019)... ... March 14, 2019 , ... ... that its Canadian partner, the Eye Machine Canada Inc., had been given approval ... technology for treating Age-Related Macular Degeneration (AMD). , The previous month, the medical ...
(Date:3/12/2019)... ... March 12, 2019 , ... ... epigenetics research, has launched its third generation long-fragment DNA shearing innovation, the Megaruptor ... with a user-friendly interface, automated processing, and the ability to process up ...
Breaking Biology Technology:
(Date:3/1/2019)... ... 2019 , ... Geneious would like to announce it is extending the reach ... , Geneious Prime already has a dedicated importer for Vector NTI Advance databases ... will be organised in Geneious in the same way. The next update (expected ...
(Date:2/26/2019)... FORT WORTH, Texas (PRWEB) , ... February 26, ... ... Manager with Lifecycle since 2018. In her position as Account Manager, Ms. Baptiste ... positively evolve the overall customer experience. Ms. Baptiste was responsible for partnering with ...
(Date:2/22/2019)... ... February 21, 2019 , ... X-ray analytical instrument manufacturer Rigaku ... the Texas Society for Microscopy ( TSM ). The event is hosted by the ... place February 21st - 23rd, 2019. Several workshops are scheduled, as well as a ...
Breaking Biology News(10 mins):